Plasma leptin and adiponectin levels in hormone replacement therapy and contraception: effects of different progestogens.

[1]  G. Adler,et al.  Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-&ggr;, and Proinflammatory Adipokines , 2008, Circulation.

[2]  P. Scherer,et al.  The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation. , 2004, Current opinion in pharmacology.

[3]  H. Escobar-Morreale,et al.  Antiandrogenic Contraceptives Increase Serum Adiponectin in Obese Polycystic Ovary Syndrome Patients , 2009, Obesity.

[4]  J. Frystyk,et al.  Effect of sex hormone treatment on circulating adiponectin and subforms in Turner and Klinefelter syndrome , 2010, European journal of clinical investigation.

[5]  T. Farley,et al.  Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. , 1995, Lancet.

[6]  D. Porte,et al.  Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans , 1996, Nature Medicine.

[7]  A. Xu,et al.  Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. , 2008, Clinical science.

[8]  C. Friedenreich,et al.  Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. , 2007, The Journal of clinical endocrinology and metabolism.

[9]  J. Jakowicki,et al.  Serum leptin concentrations in women taking oral contraceptives. , 1999, European journal of obstetrics, gynecology, and reproductive biology.

[10]  Y. Aso,et al.  The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy. , 2006, Metabolism: clinical and experimental.

[11]  G. Bifulco,et al.  Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy , 2004, Menopause.

[12]  Aging, menopause, cardiovascular disease and HRT. International Menopause Society Consensus Statement. , 2009, Climacteric : the journal of the International Menopause Society.

[13]  K. Overgaard,et al.  [Venous thromboembolic disease and oral contraceptives]. , 1986, Ugeskrift for laeger.

[14]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[15]  J. Heikkinen,et al.  Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women. , 2008, Metabolism: clinical and experimental.

[16]  J. Silha,et al.  Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. , 2004, Obesity research.

[17]  N. Barzilai,et al.  Short Term Effects of Leptin on Hepatic Gluconeogenesis and in Vivo Insulin Action* , 1997, The Journal of Biological Chemistry.

[18]  M. Kurabayashi,et al.  Plasma Adiponectin Levels in Post-menopausal Women Receiving Hormone Replacement Therapy , 2004, The Journal of international medical research.

[19]  P. Iyengar,et al.  Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. , 2003, Diabetes.

[20]  Xinliang Ma,et al.  Protective vascular and myocardial effects of adiponectin , 2009, Nature Clinical Practice Cardiovascular Medicine.

[21]  NoriyukiOuchi,et al.  Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001 .

[22]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[23]  J. Blundell,et al.  Menstrual cycle and appetite control: implications for weight regulation. , 1997, Human reproduction.

[24]  C. Christiansen,et al.  Effects of 17β‐oestradiol plus different doses of drospirenone on adipose tissue, adiponectin and atherogenic metabolites in postmenopausal women , 2005, Journal of internal medicine.

[25]  R. Kraemer,et al.  Serum leptin concentration in women: effect of age, obesity, and estrogen administration. , 1998, Fertility and sterility.

[26]  P. Chedraui,et al.  Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era. , 2009, Fertility and sterility.

[27]  M. Matsuda,et al.  Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. , 2002, Diabetes.

[28]  B. Kos-Kudła,et al.  Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. , 2005, Metabolism: clinical and experimental.

[29]  J. Chan,et al.  Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. , 2003, The Journal of clinical endocrinology and metabolism.

[30]  R. Henry,et al.  Adiponectin: more than just another fat cell hormone? , 2003, Diabetes care.

[31]  T Nakamura,et al.  An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular Walls , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[32]  F. de Zegher,et al.  Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. , 2004, The Journal of clinical endocrinology and metabolism.

[33]  S. Kihara,et al.  Obesity, adiponectin and vascular inflammatory disease , 2003, Current opinion in lipidology.

[34]  J. L. San Millán,et al.  Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. , 2006, Human reproduction.

[35]  A. O’Sullivan,et al.  Adiponectin isoform distribution in women--relationship to female sex steroids and insulin sensitivity. , 2009, Metabolism: clinical and experimental.

[36]  G. Bifulco,et al.  Effects of bilateral ovariectomy and postoperative hormonal replacement therapy with 17&bgr;-estradiol or raloxifene on serum leptin levels , 2003, Menopause.

[37]  K. Lam,et al.  Cross‐talk between adipose tissue and vasculature: role of adiponectin , 2011, Acta physiologica.

[38]  NoriyukiOuchi,et al.  Novel Modulator for Endothelial Adhesion Molecules , 1999 .

[39]  F. Orio,et al.  Evidence for altered adipocyte function in polycystic ovary syndrome. , 2005, European journal of endocrinology.

[40]  Y. Miyoshi,et al.  Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis , 2008, Breast Cancer Research and Treatment.